Rogerio Ochiai

Rogerio Ochiai has extensive experience in the pharmaceutical industry, currently serving as BU Director for Brazil at BioMarin Pharmaceutical Inc. since October 2014, focusing on enzyme therapies and hemophilia. Previously held roles include Associate Director for National and Regional Sales in Brazil and oversight of new product planning across Latin America. Rogerio's key therapeutic areas of expertise include metabolic and lysosomal storage diseases, neurometabolic conditions, and genetics. Prior to BioMarin, Rogerio held positions in strategy consulting at PwC, managing projects across various industries, including pharmaceuticals and healthcare. Rogerio holds a Bachelor's degree in Business from USP and has furthered education in data analysis and marketing.